The DREAM trial
- 1 December 2006
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 368 (9552), 2049-1
- https://doi.org/10.1016/s0140-6736(06)69826-7
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trialThe Lancet, 2006
- Systemic Immune Mediators and Lifestyle Changes in the Prevention of Type 2 DiabetesDiabetes, 2006
- Rosiglitazone Cools Down Inflammation in the Metabolic SyndromeArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or MetforminNew England Journal of Medicine, 2002
- Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose ToleranceNew England Journal of Medicine, 2001